Dr. Colleen Strain sits down with Dr. David Grenache from TriCore Reference Laboratories to tackle the topic of “Innovation in motion” in a rapid-fire dialogue and exchange.
Manager, Scientific Leadership and Education, Core Diagnostics
Colleen Strain, PhD is a Scientific Manager for Global Scientific Leadership and Education at Abbott. She is also on the scientific lead for the UNIVANTS of Healthcare Excellence program and lead for the Executive Leadership Exchange program. As a champion for laboratory medicine, Colleen is passionate about driving healthcare excellence through scientific collaborations and partnerships, while maximizing value within healthcare.
Colleen’s professional and education focus on the strategic value of laboratory medicine within healthcare. Colleen is a corporate representative on the International Federations of Clinical Chemistry (IFCC)– Task Force on Outcome Studies in Laboratory Medicine and actively supports the IFCC Task Force for Corporate Members.
Colleen Strain reported the following relevant financial disclosures:
• Salary: Abbott
• Stocks/Bonds: Abbott
Chief Scientific Officer
TriCore Reference Laboratories, USA
Dr. Grenache is the chief scientific officer for TriCore Reference Laboratories in Albuquerque, New Mexico. In that role, he leads the TriCore Research Institute and works cooperatively to develop and implement TriCore’s scientific research strategy.
He is also the laboratory director of TriCore’s flagship Core Laboratory, the medical director of immunology and of point-of-care testing, and a clinical professor of pathology at the University of New Mexico.
Dr. Grenache earned his PhD in biomedical sciences from WPI in Worcester, Massachusetts, and completed postdoctoral training in clinical chemistry at Washington University School of Medicine in St. Louis, Missouri. He is a diplomate of the American Board of Clinical Chemistry, a Fellow in the AACC Academy, and an AACC past-president. His research interests are centered on leveraging longitudinal laboratory data to gain insights into population health.
David Grenache reported no relevant financial disclosures.